-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BE9/wWPpkDlQy6TeYAg6As7SC9QHXwXZkf+Z87FVbWP96BGKhICxAirQVPHf7Zje OeySuqWX4qdP4s43CDwx/g== 0000940394-97-000315.txt : 19970728 0000940394-97-000315.hdr.sgml : 19970728 ACCESSION NUMBER: 0000940394-97-000315 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970725 SROS: NONE FILER: COMPANY DATA: COMPANY CONFORMED NAME: EV TRADITIONAL WORLDWIDE HEALTH SCIENCES FUND INC CENTRAL INDEX KEY: 0000760110 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 521378236 STATE OF INCORPORATION: MD FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 002-95103 FILM NUMBER: 97645106 BUSINESS ADDRESS: STREET 1: 24 FEDERAL STREET STREET 2: SUITE 4100 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: (617) 482-8260 MAIL ADDRESS: STREET 1: 5847 SAN FELIPE STREET 2: SUITE 4100 CITY: HOUSTON STATE: TX ZIP: 77057 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL RESEARCH INVESTMENT FUND INC DATE OF NAME CHANGE: 19920703 497 1 PROS SUPP FOR WWHSF EV TRADITIONAL WORLDWIDE HEALTH SCIENCES FUND, INC. SUPPLEMENT TO PROSPECTUS DATED FEBRUARY 1, 1997 Effective September 1, 1997, EV Traditional Worldwide Health Sciences Fund, Inc. (the "Fund"), subject to shareholder approval, will be reorganized from a Maryland corporation to Class A shares of a series fund (named Eaton Vance Worldwide Health Sciences Fund) of Eaton Vance Growth Trust, a business trust organized under the laws of the Commonwealth of Massachusetts. It is anticipated that this restructuring will reduce Fund operating expenses, thereby enhancing long-term returns and improving operational flexibility. The conversion to the multiple-class structure will not be a taxable transaction, change the value or cost basis of existing shareholders' investments, or change fund net asset values per share. Likewise, the conversion will not materially change shareholder voting rights. It is possible that some shareholders could, in the future, receive different distributions of realized capital gains than would be the case if the restructuring did not occur. This result could occur because allocation of the Worldwide Health Sciences Portfolio's current unrealized capital gains will be different under multiple-class accounting rules than has been the case under the partnership accounting rules of the current structure. The actual realization of capital gains in the future remains uncertain and depends not only on the investment adviser's decisions but also on the fluctuating market valuation of specific securities. Because capital gains distributions reduce the net asset value of a fund's shares, the effect of such a distribution change is to alter current tax obligations and tax obligations upon redemption (by the same amount). July 31, 1997 T-HS9/1PS -----END PRIVACY-ENHANCED MESSAGE-----